Skip to main content
. Author manuscript; available in PMC: 2023 Sep 12.
Published in final edited form as: J Nat Prod. 2020 Dec 22;84(1):161–182. doi: 10.1021/acs.jnatprod.0c00968

Table 4.

Validated and potential drug targets in Filoviridae and NP Inhibitors. Numbering corresponds to numbering in Figure 2. Roman numbering corresponds to numbering in Figure1. Numbers in parenthesis corresponds to structures in Figures 510

Number Target Protein Function Natural Product Inhibitors NP-Inspired Inhibitors
Viral Proteins I VP35 Polymerase cofactor responsible for transcription and replication with L protein myricetin (26), epigallocatechingallate (31) Inhibitors Needed
II VP40 Matrix protein involved in budding Inhibitors Needed Inhibitors Needed
III GP Host cell recognition ellagic acid (6), gallic acid (7), cyanovirin-N (11) triterpenoid derivatives (8, 9), a borneol derivative (10)
IV VP30 Transcriptional activator Inhibitors Needed Inhibitors Needed
V VP24 Structural protein. Important role in nucleocapsid formation Inhibitors Needed Inhibitors Needed
VI L protein RNA-dependent RNA polymerase Inhibitors Needed favipiravir (22), remdesivir (1), BCX4430 (30)
Host Proteins VII Cathepsin B / Cathepsin L Endosomal protease. Cleaves spike protein facilitating membrane fusion & entry gallinamide A (35), tokaramide A (39), miraziridine A (40) dichlorobenzyl aloperine dihydrochloride (41), E-64d (42), CA074 (43)